PULKIT NAG

With a robust background in Medical Oncology and Haemato-oncology from Apex Hospital, I excel in cancer treatment planning and analytical thinking. My work at Bhagwaan Mahaveer Cancer Hospital contributed to groundbreaking bladder cancer research. Known for exceptional multitasking and public speaking skills, I consistently deliver results beyond expectations, leveraging my comprehensive expertise in oncology.

• Association of Radiation Oncologists of India, Life Member, 2016
• European Society of Medical Oncology, Member, 2019 (ESMO)

• MBBS, 07/31/11
• MD in Radiation Oncology, 07/31/17
• DrNB in Medical Oncology, 07/31/22
• Consultant in Medical Oncology, 07/31/23

• Duodenal metastasis from carcinoma cervix: An unusual presentation and review of literature, Clinical Cancer Investigation Journal, 2016, 5, 166
• Dosimetric analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for chest wall irradiation in breast cancer patients, Journal of Radiotherapy in Practice, 2016, 15, 30-37
• Comparison of Dosimetric parameters and acute toxicity of Intensity modulated and three-dimensional radiotherapy in patients with carcinoma cervix: A randomized prospective study, Journal of Cancer Radiotherapie, 2016, 20, 370-376
• Outcome in patients of hormone receptor (HR) positive (Her 2) negative metastatic breast cancer treated with palbociclib – A real-world experience, International Journal of Molecular and Immuno Oncology, 2021, 7, 20-24, 10.25259/IJMIO_24_2021

• Gynecological malignancy
• Breast malignancy
• Head and Neck malignancy
• Gastrointestinal malignancy
• Neuro-oncology
• Hematolymphoid malignancy
• Bone and Soft tissue malignancy
• Pediatric malignancy

• MS Gujral Gold Medal, 1st prize in oral presentation in AROICON MP-CG Chapter, 2016
• 1st Prize in Poster Presentation, AROICON MP-CG Chapter, 2016
• 1st Prize in State Quiz Competition for Breast Cancer, MGH Hospital, 2021
• 1st Prize in State Quiz Competition in Precision Oncology, 2022
• Cleared ESMO Exam, 10/01/23

• Title: Consultant-Medical Oncology and Haemato-oncology
• Date of Birth: 06/24/85

• Speaker: Advances in ER +ve early breast cancer in 2024 Trends of transformation in oncology,Udaipur.
• Speaker: Osimertinib in NSCLC-Real world evievidence in 2024 Trends of transformation in oncology,Udaipur.
• Speaker : Management NSCLC with EGFR mutation in 2024 New Horizons in Oncology.
• Speaker: Clinical aspects of Trastuzumab and Nab-Apclitaxel Nov 2023 Onco Mankind.
• Speaker: Raise awareness on EGFR EXON 20 insertion mutation in Lung cancer Nov 2023 in J&J.
• Speaker: Adult Vaccination in preventable Disease feb. 2025
• Speaker: Role OFTDXD in MBC (destiny trail) in 2023 Trends of transformation in oncology,Udaipur.
• Speaker: Evolving trends in management of Her-2+ve MBC in October 2023 Trends of transformation in oncology,Udaipur.
• Speaker: Updated management of metastatic castration resistant prostrate Cancer (M1 CRPC) october 2023 Trends of transformation in oncology,Udaipur.
• Speaker: Olaparib Redifining Treatment Landscape may 2024.
• Speaker: Clinical Experience on use of Amivantamab in real world practice may 2024.
• Speaker: Newer updates in the management of 1st line BTC in Oncology Prespective 2024.
• Speaker: Oncoluxe ILLUMINATING the path forward in cancer care- SACI-I0 HR+/HER2- metastatic breast cancer June 2024.
• Speaker: Oncoluxe ILLUMINATING the path forward in cancer care- EVOKE-01: Phase III Trail of Sacituzumab Govitecan vs Docetaxel in patients with previou treated advanced NSCLC June 2024.
• Speaker: Recent advances in the management of Localized and locally advanced Non smell cell lung Cancer ( NSCLC) with EGFR mutation in Recent development in comman cancer treatment Dec. 2024.
• Speaker: Mitigating AE in prostrate cancer Focus on ADT AND ARI in Expert prostrate cancer meet current therapeutic management in prostrate Cancer 2024.
• Panelist: Solving u meet needs in CRC and NSCLC with precision medicine in Annual Oncolgy summit ,Goa Jan. 2025.
• Panelist: Improving outcomes with novel formulations of Taxances in October 2023 Trends of transformation in oncology,Udaipur.
• Panelist: Selecting Operable breast cancers patients for Neo Adjuvant Treatment in 7th Annual IBCC October 2023 Jaipur.
• Panelist: The Emergence oral GnRH Antagonist in PRIME Conclave Jan 2024.
• Panelist: Digital Advisory board meeting NuPARP inhibitors - Chamging treatment landscape in management of Ovarian Cancer and Beyond Feb. 2024.
• Panelist: Shingles prevention in general and Immunicompromised population may 2024.
• Panelist: PACE ( Prostate cancer assembly for continued excellence ) July 2024.
• Panelist: Immune checkpoint Inhinitors in 1L Gastric Cancer, GE Junction Cancer & Esophageal Adenocarcinomas in Oncology updates experts and evidence August 2024. New Delhi.
• Panellist: Olaparib: Role of PARP inhibitors beyond BRCA Sep. 2024.
• Panelist: discussion on rare mutations in NSCLC in ISMPO-CON oct. 2024.
• Panelist: discussion Case base on LA NSCLC in updates in clinical Oncology 2024.
• Panelist: Navigating treatment options on HR+ve and Herve Breast cancer in Womclave Meet Nov. 2024.
• Panelist: PATINA trail, Destiny Breast 06 TRAIL ,PADMA TRAIL EMBER-3 Trail in Pink Conclave - SABC highlights Jan 2025.
• Thesis accepted for Poster presen in ESMO Asia Singapore December 2022.
• Pulkit Nag , Virendra Bhandari,Mehlam Kausar, Harsh Goyal:Duodenal metastatasis from carcinoma cervix : An unusual presentation and Review of literature - Oral presentation in AROICON MP-CG CHAPTER INDORE-2016.
• Pulkit Nag , Virendra Bhandari,Mehlam Kausar, Harsh Goyal:Duodenal metastatasis from carcinoma cervix : An unusual presentation and Review of literature- Poster Presentation in Indian Society of Medical and Pediatric Oncology (ISMPO) Delhi- 2015.